BioSpace News Archive

BioMidwest

Fresenius Kabi Introduces Adenosine Injection, USP in 60 mg per 20 mL and 90 mg per 30 mL Presentations

Complete portfolio of all commonly used sizes and strengths of Adenosine Injection, USP now available from Fresenius Kabi

July 10, 2018
·
3 min read
Deals

GHX Announces Agreement to Acquire Majority of Assets of Medical Columbus

GHX to add solutions in Germany, Switzerland, Austria, Luxembourg and the Netherlands, expanding its supply chain business process network for both healthcare providers and suppliers

July 10, 2018
·
3 min read
Pharm Country

Nanotronics Unveils New Products Driven by Advances in Artificial Intelligence and Machine Learning at SEMICON WEST 2018

Nanotronics is debuting new microscopy products and software capabilities at the flagship U.S. event for connecting the electronics manufacturing supply chain this week, SEMICON West 2018.

July 10, 2018
·
2 min read
Business

Ross University School of Veterinary Medicine Opens Research and Pathology Building

A facility for multidisciplinary research to benefit human and animal health in the Caribbean

July 10, 2018
·
5 min read
Business

Shark Tank Original Member Kevin Harrington Joins Forces with UVLrx Therapeutics, Inc.

Harrington will oversee the marketing and growth trajectory of the company’s multiple-wavelength intravenous light therapy devices

July 10, 2018
·
2 min read
FDA

FDA’s Approval of T2 Biosystems T2Bacteria Panel Underlines Importance of Sepsis Diagnosis and Treatment

On May 29, the FDA cleared T2 Biosystems’ T2Bacteria Panel for diagnosis of sepsis. In that sepsis is the third-leading cause of death in the U.S., this emphasizes the importance of work in this area.

July 10, 2018
·
4 min read
·
Mark Terry
Drug Development

Beleaguered Regulus Therapeutics Slashes 60 Percent of Workforce in New Corporate Restructuring

Shares of Regulus Therapeutics saw something of a slight rally on Monday following a post-Independence Day corporate restructuring announcement that included the termination of 60 percent of its workforce, which caused a massive stock plummet.

July 10, 2018
·
3 min read
·
Alex Keown
Policy

Former Rockwell Medical CEO Files Lawsuit, Company Files Counter Lawsuit in Ongoing Legal Battle

Legal battles are continuing between the Rockwell Medical Board of Directors and two senior executives who were fired earlier this year.

July 10, 2018
·
3 min read
·
Alex Keown
Drug Development

Celgene and Acceleron’s Luspatercept Hits Primary Endpoints in Beta-Thalassemia Trial

Celgene Corporation and Acceleron Pharma indicated their Phase III clinical trial of luspatercept in beta-thalassemia hit its primary endpoint of erythroid response.

July 10, 2018
·
3 min read
·
Mark Terry
Policy

Trump Decries Pfizer Over Second Round of Price Increases for Prescriptions

President Donald Trump used the power of his Twitter feed to call out and condemn pharma giant Pfizer after that company increased the price of a number of its prescription medications by nearly 10 percent.

July 10, 2018
·
2 min read
·
Alex Keown